Global Chemotherapy Infusion Pumps Market Share Analysis 2024, Forecast To 2033
10 Oct, 2024
The chemotherapy infusion pump market size has grown strongly in recent years, reaching $4.64 billion in 2023 and is projected to grow to $4.92 billion in 2024 at a CAGR of 6.1%. The growth during this period is driven by factors such as the shift to outpatient care, increasing cancer incidence, healthcare infrastructure development, aging populations, and rising healthcare expenditure. Looking ahead, the market is expected to continue growing, reaching $6.26 billion in 2028 at a CAGR of 6.2%. This future growth will be driven by the expansion of home healthcare, the rising incidence of cancer, increased awareness and screening programs, favorable regulatory policies, and the faster approval of new medical devices. Key trends for the coming years include the integration of smart technologies, home-based chemotherapy treatments, an emphasis on advanced safety features in pumps, customization and precision infusion technologies, and enhanced integration with electronic health record (EHR) systems.
Major Driver In The Chemotherapy Infusion Pumps Market
The increasing incidence of cancer is projected to drive growth in the chemotherapy infusion pumps market in the coming years. Cancer is characterized by the uncontrolled proliferation and spread of abnormal cells, influenced by lifestyle changes, genetic predispositions, and environmental factors such as smoking, radiation, chemicals, and infectious agents. Chemotherapy infusion pumps are vital for cancer patients, delivering precise, continuous doses of chemotherapy drugs, thereby optimizing administration and minimizing side effects. For example, in February 2024, the World Health Organization reported that over 35 million new cancer cases are anticipated in 2050, marking a 77% increase from the estimated 20 million cases in 2022. Consequently, the rising incidence of cancer is expected to bolster the chemotherapy infusion pump market, with market sizes projected to reach USD 3.21 billion in 2023, USD 3.75 billion in 2024, and USD 5.12 billion by 2028.
Request A Free Sample Of The Chemotherapy Infusion Pumps Market ReportChemotherapy Infusion Pumps Market Competitive Landscape
Major companies operating in the chemotherapy infusion pumps market are Johnson & Johnson Services Inc., Medtronic plc, Becton Dickinson and Company, Baxter International Inc., Medline Industries LP, B. Braun Holding GmbH & Co. KG, Fresenius Kabi AG, Grifols S.A., Terumo Corporation, Nipro Corporation, Smiths Group plc, Moog Inc., Avanos Medical Inc., Halyard Health, Vygon SAS, Palex Medical SA, Samtronic SA, ICU Medical Inc., Pfm Medical Ag, Zyno Medical LLC, Leventon S.A.U., InfuTronix Solutions LLC, Heka Healthcare, PROMECON GmbH
Key Chemotherapy Infusion Pumps Market Trend
Major companies in the chemotherapy infusion pumps market are innovating advanced technologies, such as customizable infusion rates for multiple chemotherapy drugs, to facilitate more personalized and precise treatment plans. Customizable infusion rates for chemotherapy infusion pumps enable healthcare providers to adjust the speed and dosage of chemotherapy drug delivery based on each patient’s specific needs. For instance, in May 2023, Mindray, a China-based medical device and solution provider, launched an innovative infusion mode called "Rhythm Dose" in their latest BeneFusion i/u infusion pump series. This advanced feature is specifically tailored to optimize the delivery of chemotherapy drugs, allowing healthcare professionals to administer continuous intravenous infusions of various chemotherapy drugs at different rates, thereby enabling more personalized treatment strategies.
Purchase The Global Chemotherapy Infusion Pumps Market Report Directly And Get A Swift DeliveryGlobal Chemotherapy Infusion Pumps Market Segmentation
The chemotherapy infusion pumps market covered in this report is segmented –
1) By Type: Large Volume Pumps, Syringe Pump, Elastomeric Pumps, Ambulatory Infusion Pumps, Other Types
2) By Usage: Disposable, Reusable
3) By End User: Hospitals, Clinics, Home Care, Other End Users
By Geography:The regions covered in the chemotherapy infusion pumps market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
North America was the largest region in the chemotherapy infusion pump market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period.
The Chemotherapy Infusion Pumps Global Market Report 2024 furnishes information about the global chemotherapy infusion pumps market, encompassing details like market size, projections for growth, segmentation across various sectors and regions, and an overview of competitors, including their revenues, profiles, and market shares. Furthermore, the report pinpoints potential opportunities and strategic directions derived from market trends and the strategies adopted by key competitors. The report also offers an assessment of how the COVID-19 pandemic, the Russia-Ukraine conflict, and increasing inflation have affected both global and regional markets, furnishing valuable strategic insights for businesses.